keyword
https://read.qxmd.com/read/38565499/comparing-the-effect-of-early-versus-delayed-metformin-treatment-on-glycaemic-parameters-among-australian-adults-with-incident-diabetes-evidence-using-a-national-general-practice-database
#21
JOURNAL ARTICLE
Mingyue Zheng, Mumtaz Begum, Carla De Oliveira Bernardo, Nigel Stocks, David Gonzalez-Chica
PURPOSE: To compare the effect of early vs delayed metformin treatment for glycaemic management among patients with incident diabetes. METHODS: Cohort study using electronic health records of regular patients (1+ visits per year in 3 consecutive years) aged 40+ years with 'incident' diabetes attending Australian general practices (MedicineInsight, 2011-2018). Patients with incident diabetes were defined as those who had a) 12+ months of medical data before the first recording of a diabetes diagnosis AND b) a diagnosis of 'diabetes' recorded at least twice in their electronic medical records or a diagnosis of 'diabetes' recorded only once combined with at least 1 abnormal glycaemic result (i...
April 1, 2024: Clinical Therapeutics
https://read.qxmd.com/read/38564158/can-general-practitioner-opioid-prescribing-to-compensated-workers-with-low-back-pain-be-detected-using-administrative-payments-data-an-exploratory-study
#22
JOURNAL ARTICLE
Jennifer Vo, Shannon Gray, Adrian C Traeger, Michael Di Donato
BACKGROUND: Approximately one third of Australians with accepted time loss workers' compensation claims for low back pain (LBP) are dispensed opioid analgesics. Structured administrative payments data is scalable but does not directly link opioids to prescribers. We sought to determine whether opioid prescribing by general practitioners (GPs) to workers with workers' compensation claims for LBP can be detected in structured administrative payments data. METHODS: We used a sample of workers with accepted time loss workers' compensation claims for low back pain from 2011 to 2015 from the Australian states of Victoria and South Australia...
April 2, 2024: Journal of Occupational Rehabilitation
https://read.qxmd.com/read/38561957/implementation-of-a-quality-improvement-strategy-to-optimise-the-management-of-community-acquired-pneumonia-in-a-rural-health-setting
#23
JOURNAL ARTICLE
Carrington Sally, Chau Gabrielle, Miller Waugh Sidony, Symmons Christopher, Titmarsh Justin, Minyon L Avent
PROBLEM: In Australia, inappropriate prescribing of antimicrobials is higher in rural and regional areas than in major city hospitals. Inappropriate prescribing is defined as the prescription of antimicrobial agents that do not adhere to guidelines in terms of type of antimicrobial chosen, dose and/or duration or are deemed unnecessary. A review of antimicrobial prescribing in a Queensland rural Hospital and Health Service (HHS) identified that respiratory infections were an area for potential improvement...
April 1, 2024: Australian Journal of Rural Health
https://read.qxmd.com/read/38561896/drug-dependence-and-prescribing-ketamine-for-treatment-resistant-depression-in-australia-and-new-zealand
#24
JOURNAL ARTICLE
Alistair Carroll, Adam Bayes, Mark Montebello, Jonathan Brett, Shalini Arunogiri, John B Saunders, Colleen K Loo
Ketamine is a restricted and regulated medication in Australia and New Zealand, which has implications when considering treatment for patients with treatment-resistant depression and a history of illicit drug use, abuse or dependence. Regulations governing prescription of ketamine for treatment-resistant depression vary between jurisdictions in Australia and New Zealand, though most restrict use in those with drug dependence. There is substantial variation in definitions of drug dependence used in each jurisdiction, and between the legal and clinical definitions, with the latter specified in the current International Classification of Diseases, Eleventh Revision and Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition...
April 1, 2024: Australian and New Zealand Journal of Psychiatry
https://read.qxmd.com/read/38560602/risk-of-primary-incident-hepatitis-c-infection-following-bacterial-sexually-transmissible-infections-among-gay-and-bisexual-men-in-australia-from-2016-to-2020
#25
JOURNAL ARTICLE
Brendan L Harney, Rachel Sacks-Davis, Paul Agius, Daniela K van Santen, Michael W Traeger, Anna L Wilkinson, Jason Asselin, Christopher K Fairley, Norman Roth, Mark Bloch, Gail V Matthews, Basil Donovan, Rebecca Guy, Mark Stoové, Margaret E Hellard, Joseph S Doyle
BACKGROUND: In Australia, the incidence of hepatitis C virus (HCV) has declined among gay and bisexual men (GBM) with human immunodeficiency virus (HIV) since 2015 and is low among GBM using HIV preexposure prophylaxis (PrEP). However, ongoing HCV testing and treatment remains necessary to sustain this. To assess the potential utility of sexually transmissible infections (STIs) to inform HCV testing among GBM with HIV and GBM using PrEP, we examined the association between bacterial STI diagnoses and subsequent primary HCV infection...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38560547/evaluation-of-the-quality-and-safety-of-venous-thromboembolism-prophylaxis-among-gastroenterology-inpatients-at-a-tertiary-hospital-in-australia
#26
JOURNAL ARTICLE
Nameer van Oosterom, Keshia R De Guzman, Karl Winckel, Anissa Johnson, Nazanin Falconer
Background and objective : Hospital acquired venous thromboembolisms (VTEs) are common and preventable. The Queensland Health VTE prophylaxis guidelines, developed in 2018, provide guidance for risk assessment, and prescribing of anticoagulation for prophylaxis and treatment of hospital inpatients. Currently, there are limited recommendations for gastroenterology patients. This study investigated the completion of VTE risk assessments, and the appropriateness of VTE prophylaxis regimens, in accordance with Queensland Health guidelines for gastroenterology patients...
December 2023: Hospital Pharmacy
https://read.qxmd.com/read/38537295/poor-policy-and-inadequate-regulation-of-medical-technology-is-driving-low-value-care-in-australia-s-private-health-system
#27
JOURNAL ARTICLE
Rachel David
Millions of Australians use the private health system every year. They should receive safe, high-quality, value-based care. However, poor policy and inadequate regulation of medical technology is driving low-value care at great expense to consumers and the broader health system. Key drivers include the Prescribed List of Medical Devices and Human Tissue, gaps in quality and safety controls for devices being used, and marketing and conflicts of interest. All of these should be addressed to reduce low-value care in Australia's private health system, so consumers are protected from harm and limited health budgets are used effectively...
March 28, 2024: Australian Health Review: a Publication of the Australian Hospital Association
https://read.qxmd.com/read/38525724/influences-of-software-changes-on-oxycodone-prescribing-at-an-australian-tertiary-emergency-department-a-retrospective-review
#28
JOURNAL ARTICLE
Giles Barrington, Katherine Davis, Zach Aandahl, Brodie-Anne Hose, Mitchell Arthur, Viet Tran
Opioid prescribing and dispensing from emergency departments is a noteworthy issue given widespread opioid misuse and diversion in many countries, contributing both physical and economic harm to the population. High patient numbers and the stochastic nature of acute emergency presentations to emergency departments (EDs) introduce challenges for prescribers who are considering opioid stewardship principles. This study investigated the effect of changes to electronic prescribing software on prescriptions with an auto-populated quantity of oxycodone immediate release (IR) from an Australian tertiary emergency department following the implementation of national recommendations for reduced pack sizes...
March 1, 2024: Pharmacy (Basel, Switzerland)
https://read.qxmd.com/read/38514141/identifying-provider-patient-and-practice-factors-that-shape-long-term-opioid-prescribing-for-cancer-pain-a-qualitative-study-of-american-and-australian-providers
#29
JOURNAL ARTICLE
Soraya Fereydooni, Karl Lorenz, Azin Azarfar, Tim Luckett, Jane L Phillips, William Becker, Karleen Giannitrapani
INTRODUCTION: Prescribing long-term opioid therapy is a nuanced clinical decision requiring careful consideration of risks versus benefits. Our goal is to understand patient, provider and context factors that impact the decision to prescribe opioids in patients with cancer. METHODS: We conducted a secondary analysis of the raw semistructured interview data gathered from 42 prescribers who participated in one of two aligned concurrent qualitative studies in the USA and Australia...
March 21, 2024: BMJ Open
https://read.qxmd.com/read/38506546/telehealth-during-covid-19-restrictions-in-patients-with-cardiovascular-disease-impact-on-medication-prescriptions-and-patient-satisfaction
#30
JOURNAL ARTICLE
Nestor Gahungu, Nick S R Lan, Sameera Gamalath, Jane Phan, Vikas Bhat, Rhys Spencer, Sarah A Hitchen, James M Rankin, Girish Dwivedi, Abdul Rahman Ihdayhid
BACKGROUND AND AIMS: Telehealth plays an integral part in healthcare delivery. The impact of telehealth and the COVID-19 pandemic on medication prescribing and patient satisfaction with telehealth in cardiology clinics remains unknown. METHODS: A retrospective study of cardiology clinic patients at an Australian tertiary hospital was conducted; 630 patients seen before the COVID-19 pandemic (0.6% telehealth) and 678 during the pandemic (91.2% telehealth) were included...
March 20, 2024: Internal Medicine Journal
https://read.qxmd.com/read/38502366/safety-and-effectiveness-of-janus-kinase-inhibitors-in-the-management-of-inflammatory-bowel-disease-following-liver-transplantation
#31
JOURNAL ARTICLE
Danny Con, Patrick Hilley, Simone Chin, Crispin Corte, Bilal Hafeez, Adam Testro, Peter De Cruz, Matthew Choy, Ashish Srinivasan
BACKGROUND: The management of inflammatory bowel disease (IBD) patients with concurrent liver transplantation is challenging, and data regarding the safety and efficacy of Janus kinase (JAK) inhibitors with anti-rejection medications are required. We report the experience of all liver transplant recipients receiving tofacitinib and/or upadacitinib for IBD across three states in Australia. METHODS: All liver transplant recipients from the Australian states of Victoria, New South Wales and Tasmania who required tofacitinib or upadacitinib for the treatment of IBD were identified using prospectively maintained liver transplant databases...
March 19, 2024: Journal of Crohn's & Colitis
https://read.qxmd.com/read/38490692/postoperative-pain-and-pain-management-following-selective-dorsal-rhizotomy
#32
JOURNAL ARTICLE
Isabel G Adams, Ramanie Jayaweera, Jennifer Lewis, Nadia Badawi, Mohamed E Abdel-Latif, Simon Paget
BACKGROUND: Selective dorsal rhizotomy (SDR) is a neurosurgical procedure that reduces lower limb spasticity, performed in some children with spastic diplegic cerebral palsy. Effective pain management after SDR is essential for early rehabilitation. This study aimed to describe the anaesthetic and early pain management, pain and adverse events in children following SDR. METHODS: This was a retrospective cohort study. Participants were all children who underwent SDR at a single Australian tertiary hospital between 2010 and 2020...
March 15, 2024: BMJ Paediatrics Open
https://read.qxmd.com/read/38486961/antipsychotic-prescribing-patterns-in-children-and-adolescents-attending-australian-general-practice-in-2011-and-2017
#33
JOURNAL ARTICLE
Julie Klau, David Gonzalez-Chica, Melissa Raven, Jon Jureidini
BACKGROUND: Antipsychotics are increasingly prescribed to children and adolescents worldwide, but little is known about reasons for prescribing. We aimed to examine patterns of paediatric antipsychotic prescribing in Australian primary care services in 2011 and 2017, including diagnoses, sociodemographic characteristics, off-label prescribing, and psychotropic co-prescribing. METHODS: Retrospective analysis of electronic health records (EHRs) using a large Australian general practice database (MedicineInsight)...
March 2024: JCPP Adv
https://read.qxmd.com/read/38479733/reinforcing-informed-medication-prescription-for-low-back-pain-in-the-emergency-department-rime-a-controlled-interrupted-time-series-implementation-study-protocol
#34
JOURNAL ARTICLE
Shaun O'Leary, Janelle Heine, Jacelle Warren, Tanya Smyth, Emma Ballard, Gary Mitchell, William See, Panos Barlas, Gustavo C Machado, Michelle Cottrell, Tracy Comans, Nadine E Foster
INTRODUCTION: Management guidelines for low back pain (LBP) recommend exclusion of serious pathology, followed by simple analgesics, superficial heat therapy, early mobilisation and patient education. An audit in a large metropolitan hospital emergency department (ED) revealed high rates of non-recommended medication prescription for LBP (65% of patients prescribed opioids, 17% prescribed benzodiazepines), high inpatient admission rates (20% of ED LBP patients), delayed patient mobilisation (on average 6 hours) and inadequate patient education (48% of patients)...
March 12, 2024: BMJ Open
https://read.qxmd.com/read/38479437/australian-consensus-statement-on-doxycycline-post-exposure-prophylaxis-doxy-pep-for-the-prevention-of-syphilis-chlamydia-and-gonorrhoea-among-gay-bisexual-and-other-men-who-have-sex-with-men
#35
JOURNAL ARTICLE
Vincent J Cornelisse, Benjamin Riley, Nicholas A Medland
INTRODUCTION: Doxycycline post-exposure prophylaxis (doxy-PEP) involves consuming 200 mg of doxycycline up to 72 hours after a condomless sex act to reduce the risk of bacterial sexually transmitted infections (STIs). Recent clinical trials of doxy-PEP have demonstrated significant reductions in syphilis, chlamydia and, to a lesser degree, gonorrhoea among gay, bisexual and other men who have sex with men (GBMSM). There is a high level of interest in doxy-PEP in the GBMSM community and, in response, the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) held a national consensus conference with the aim of creating preliminary guidance for clinicians, community, researchers and policy makers...
March 13, 2024: Medical Journal of Australia
https://read.qxmd.com/read/38462996/use-of-thyroid-hormones-in-hypothyroid-and-euthyroid-patients-a-survey-of-members-of-the-endocrine-society-of-australia
#36
JOURNAL ARTICLE
Nicole Lafontaine, Suzanne J Brown, Petros Perros, Enrico Papini, Endre V Nagy, Roberto Attanasio, Laszlo Hegedüs, John P Walsh
OBJECTIVE: Hypothyroidism is a common endocrine condition usually managed with levothyroxine (LT4). However, controversy remains around the use of liothyronine (LT3). We aimed to investigate the practices of Australian endocrinologists when managing patients with hypothyroidism, their use of LT3 + LT4 combination therapy and use of thyroid hormones in euthyroid patients. DESIGN AND PARTICIPANTS: Members of the Endocrine Society of Australia (ESA) were invited to participate in an online questionnaire...
March 11, 2024: Clinical Endocrinology
https://read.qxmd.com/read/38458796/association-between-long-term-use-of-calcium-channel-blockers-ccb-and-the-risk-of-breast-cancer-a-retrospective-longitudinal-observational-study-protocol
#37
JOURNAL ARTICLE
Chau Ho, Ninh Thi Ha, David Youens, Walter P Abhayaratna, Max K Bulsara, Jeffery David Hughes, Gita Mishra, Sallie-Anne Pearson, David B Preen, Christopher M Reid, Rikje Ruiter, Christobel M Saunders, Bruno H Stricker, Frank J A van Rooij, Cameron Wright, Rachael Moorin
INTRODUCTION: Calcium channel blockers (CCB), a commonly prescribed antihypertensive (AHT) medicine, may be associated with increased risk of breast cancer. The proposed study aims to examine whether long-term CCB use is associated with the development of breast cancer and to characterise the dose-response nature of any identified association, to inform future hypertension management. METHODS AND ANALYSIS: The study will use data from 2 of Australia's largest cohort studies; the Australian Longitudinal Study on Women's Health, and the 45 and Up Study, combined with the Rotterdam Study...
March 8, 2024: BMJ Open
https://read.qxmd.com/read/38450897/long-term-outcomes-of-definitive-radiation-with-volumetric-modulated-arc-therapy-and-concurrent-chemotherapy-for-squamous-cell-carcinoma-of-the-anus-in-a-regional-australian-cancer-centre
#38
JOURNAL ARTICLE
Michael Ti Hsieh, Thomas Philip Shakespeare, Lauren Winkley, Daniel Goonetilleke, Shaun Zheng Liang Yap, Abdul Rahim Mohd Tahir
INTRODUCTION: Concurrent chemoradiotherapy is the standard of care in the curative intent treatment of squamous cell carcinoma (SCC) of the anus. Volumetric arc therapy (VMAT) is a highly conformal radiation therapy technique that has been implemented to reduce toxicity for these patients. However, there are few reports evaluating the long-term outcomes of VMAT. Thus, we evaluated the survival and toxicity outcomes of anal cancer patients treated in our regional cancer centre undergoing curative intent chemoradiotherapy using VMAT and following the Australian EviQ guidelines...
March 7, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38447549/age-and-sex-disparities-in-cardiovascular-risk-factor-management-prior-to-stroke-linked-registry-and-general-practice-data
#39
JOURNAL ARTICLE
Kiran Bam, Monique F Kilkenny, Joosup Kim, Dominique A Cadilhac, Christopher Pearce, Nadine E Andrew, Lauren Sanders, Amanda G Thrift, Mark R Nelson, Seana Gall, Galina Daraganova, Muideen T Olaiya
INTRODUCTION: There is limited evidence about the management of cardiovascular risk factors within 12 months before stroke/transient ischaemic attack (TIA) in Australian general practices. We evaluated whether age and sex disparities in cardiovascular risk factor management for primary prevention exist in general practice. METHODS: A retrospective cohort study using data from the Australian Stroke Clinical Registry (2014-2018) linked with general practice data from three primary health networks in Victoria, Australia...
March 6, 2024: Neuroepidemiology
https://read.qxmd.com/read/38444897/managing-hypercholesterolaemia
#40
REVIEW
Adam J Nelson, Stephen J Nicholls
Hypercholesterolaemia is one of the most common conditions treated by clinicians in Australia. Low-density lipoprotein cholesterol (LDL-C) plays a causal role in the development and progression of atherosclerosis and cardiovascular disease. Every 1 mmol/L reduction in LDL-C concentration is associated with a 21 to 25% reduction in the relative risk of prospective atherosclerotic cardiovascular events, and emerging evidence suggests this benefit increases over time. Absolute cardiovascular risk assessment identifies patients likely to derive the most benefit from lowering LDL-C concentration, and helps determine the intensity of their treatment regimens and targets...
February 2024: Australian Prescriber
keyword
keyword
22484
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.